Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Eun Sil Koh"
Filter
Filter
Article type
Keywords
Publication year
Authors
Funded articles
Review Article
Diabetes, obesity and metabolism
Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis
Eun Sil Koh, Gheun-Ho Kim, Sungjin Chung
Endocrinol Metab. 2023;38(4):359-372.   Published online July 24, 2023
DOI: https://doi.org/10.3803/EnM.2023.1764
  • 14,898 View
  • 761 Download
  • 17 Web of Science
  • 25 Crossref
AbstractAbstract PDFPubReader   ePub   
When sodium-glucose cotransporter-2 (SGLT2) inhibitors were first introduced a decade ago, no one expected them to have substantial effects beyond their known glucose-lowering effects, until the emergence of evidence of their robust renal and cardiovascular benefits showing that they could attenuate progression of kidney disease, irrespective of diabetes, as well as prevent the development of acute kidney injury. Still, the precise and elaborate mechanisms underlying the major organ protection of SGLT2 inhibitors remain unclear. SGLT2 inhibitors inhibit the reabsorption of sodium and glucose in the proximal tubule of the kidney and then recovers tubuloglomerular feedback, whereby SGLT2 inhibitors reduce glomerular hyperfiltration. This simple demonstration of their beneficial effects has perplexed experts in seeking more plausible and as yet undisclosed explanations for the whole effects of SGLT2 inhibitors, including metabolism reprogramming and the modulation of hypoxia, inflammation, and oxidative stress. Given that the renal benefits of SGLT2 inhibitors in patients with kidney disease but without diabetes were comparable to those seen in patients with diabetes, it may be reasonable to keep the emphasis on their hemodynamic actions. In this context, the aim of the present review is to provide a comprehensive overview of renal hemodynamics in individuals with diabetes who are treated with SGLT2 inhibitors, with a focus on natriuresis associated with the regulation of tubuloglomerular feedback and potential aquaresis. Throughout the discussion of alterations in renal sodium and water transports, particular attention will be given to the potential enhancement of adenosine and its receptors following SGLT2 inhibition.

Citations

Citations to this article as recorded by  
  • Sodium‐glucose cotransporter 2 inhibitor ameliorates thiazolidinedione‐induced fluid retention through vascular leakage reduction in white adipose tissue
    Ji Yoon Kim, Hye‐Min Jang, Hye‐Jin Lee, Ah Hyeon Lee, Dong‐Hoon Kim, Sin Gon Kim, Nam Hoon Kim
    Diabetes, Obesity and Metabolism.2026; 28(3): 1764.     CrossRef
  • Molecular mechanisms of PCSK9 in cardiology: therapeutic implications and clinical impacts on the cardiorenal axis
    Sandeep Kaur, Drishti Panjwani, Shareen Singh, Souvik Banerjee, Sukriti Wadehra, Amritpal Kaur, Thakur Gurjeet Singh
    Molecular and Cellular Biochemistry.2026;[Epub]     CrossRef
  • Hepatorenal vulnerability flagged by glomerular hyperfiltration in metabolic liver disease: a large health-screening cohort evidence
    Dae-Jeong Koo, Yun Tae Kim, Sun-Joon Moon, Hyemi Kwon, Se Eun Park, Sang Min Lee, Cheol-Young Park, Won-Young Lee, Sung Rae Cho, Eun-Jung Rhee
    Diabetology & Metabolic Syndrome.2026;[Epub]     CrossRef
  • Effects of SGLT2 inhibitors on NSAID-associated acute kidney injury in type 2 diabetes: a claims-based cohort study
    Yuki Kunitsu, Hiroyoshi Koide, Keiko Ikuta, Daiki Hira, Shunsaku Nakagawa, Masahiro Tsuda, Shin-Ya Morita, Tomohiro Terada
    BMC Nephrology.2026;[Epub]     CrossRef
  • Redefining SGLT2 inhibitors through cytoprotective mechanisms
    Sanja Stankovic, Zoran Miloradovic, Vladimir Petrovic, Milan Stoiljkovic
    European Journal of Pharmacology.2026; 1016: 178647.     CrossRef
  • Analysis of the Endocrine Responses to Anti-Diabetes Drugs: An Issue of Elevated Plasma Renin Concentration in Sodium-Glucose Co-Transporter 2 Inhibitor
    Cheng-Wei Lin, Shih-Yuan Hung, I-Wen Chen
    International Journal of General Medicine.2025; Volume 18: 135.     CrossRef
  • Advances in understanding and managing diabetic kidney disease: An updated review
    Elmukhtar Habas, Amnna Rayani, Aml Habas, Kalifa Farfar, Eshrak Habas, Khaled Alarbi, Ala Habas, Elmehdi Errayes, Gamal Alfitori
    Ukrainian Journal of Nephrology and Dialysis.2025; (1(85)): 66.     CrossRef
  • Dietary Polyunsaturated Fatty Acid Deficiency Impairs Renal Lipid Metabolism and Adaptive Response to Proteinuria in Murine Renal Tubules
    Yaping Wang, Pan Diao, Daiki Aomura, Takayuki Nimura, Makoto Harada, Fangping Jia, Takero Nakajima, Naoki Tanaka, Yuji Kamijo
    Nutrients.2025; 17(6): 961.     CrossRef
  • Diuretics: a review of the pharmacology and effects on glucose homeostasis
    Mauricio Di Fulvio, Yakshkumar Dilipbhai Rathod, Shorooq Khader
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • SGLT2 Inhibitors in Cancer Patients: A Comprehensive Review of Clinical, Biochemical, and Therapeutic Implications in Cardio-Oncology
    Alessandra Greco, Maria Laura Canale, Vincenzo Quagliariello, Stefano Oliva, Andrea Tedeschi, Alessandro Inno, Marzia De Biasio, Irma Bisceglia, Luigi Tarantini, Nicola Maurea, Alessandro Navazio, Marco Corda, Attilio Iacovoni, Furio Colivicchi, Massimo G
    International Journal of Molecular Sciences.2025; 26(10): 4780.     CrossRef
  • Dual-faced guardians: SGLT2 inhibitors’ kidney protection and health challenges: a position statement by Kasralainy nephrology group (KANG)
    Amin Roshdy Soliman, Mohamed Elkhatib, Sahier El-Khashab, Rasha Ahmed Darwish, Ahmed Fayed, Tarek S. Abdelaziz, Hany Hammad, Rabab Mahmoud Ahmed, Hoda Abdelhamid Maamoun
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Cardiovascular and Renal Outcomes Following Repeated Naringenin Exposure in Normotensive and Hypertensive Rats
    Anelize Dada, Rita de Cássia Vilhena da Silva, Mariana Zanovello, Anelise Felício Macarini, Thaise Boeing, Valdir Cechinel Filho, Priscila de Souza
    Pharmaceuticals.2025; 18(6): 873.     CrossRef
  • Investigating the effect of SGLT2 inhibitors on cardiovascular related health status in HFmrEF and HFpEF: systematic review and meta analysis
    Tabitha Kusi-Yeboah, Isaac Gianfrancesco, Muzammil Arif Din Abdul Jabbar, Phoebe Collins, Dalton James Bally, Juliet Thornton, Kieran Williams, Ayoola Ishola, Lucy Hong, Ping Jing Toong, Milindu Wickramarachchi
    Frontiers in Cardiovascular Medicine.2025;[Epub]     CrossRef
  • Sodium-glucose co-transporter 2 inhibitor-induced increase in adenosine promotes lipolysis and weight reduction by activating reno-adipose autonomic neurocircuitry
    Aika Hagiwara, Shintaro Yamaguchi, Kazutoshi Miyashita, Kenichiro Kinouchi, Kaori Hayashi, Hiroshi Itoh
    Hypertension Research.2025; 48(10): 2664.     CrossRef
  • Chronic kidney disease in the primary care setting: A narrative review
    Faryal Safdar, Ahsan Aslam
    Journal of General and Family Medicine.2025; 26(5): 385.     CrossRef
  • Determining the role of SGLT2 inhibitors (dapagliflozin) on progression of proteinuria among non-diabetic adult patients with chronic kidney disease: a randomized controlled trial
    Shivam Srivastava, Saurabh Agarwal, Yuvraj Gulati, Alok Kumar Singh, Prakhar Aggarwal
    International Journal of Advances in Medicine.2025; 12(6): 553.     CrossRef
  • 2025 Taiwan consensus recommendations for primary care of chronic kidney disease
    Yi-Chun Tsai, Pei-Yu Wu, Tai-Shuan Lai, Chih-Chien Sung, Yi-Wen Chiu, Shang-Jyh Hwang, Yung-Ho Hsu, Mai-Szu Wu, Chung-Liang Shih
    Journal of the Formosan Medical Association.2025;[Epub]     CrossRef
  • Bridging Cardiorenal and Hepatic Disease: The Emerging Role of SGLT2 Inhibitors in Cirrhosis
    Omar Alkasabrah, Sameeha Ibrahim, Abdullah Hafeez, Muhammad Qasim Chaudhry, Faiza Jajja, Maharshi Raval, Hritvik Jain, Darshil Maheta, Siddharth Pravin Agrawal, William H. Frishman, Wilbert S. Aronow
    Cardiology in Review.2025;[Epub]     CrossRef
  • Efficacy and safety of metformin versus empagliflozin on chronic kidney disease progression (MET-EMPA-CKD): a randomized controlled trial
    Bassant M. Mahboub, Ayman F. Refaie, Sahar M. El-Haggar, Yasser M. Hafez, Tarek M. Mostafa
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Results from a cross-specialty consensus on optimal management of patients with chronic kidney disease (CKD): from screening to complications
    Mustafa Arici, Samir Helmy Assaad-Khalil, Marcello Casaccia Bertoluci, Jason Choo, Yau-Jiunn Lee, Magdalena Madero, Guillermo Javier Rosa Diez, Vicente Sánchez Polo, Sungjin Chung, Teerawat Thanachayanont, Carol Pollock
    BMJ Open.2024; 14(3): e080891.     CrossRef
  • Chronic Kidney Disease and SGLT2 Inhibitors
    Eun Sil Koh, Sungjin Chung
    The Journal of Korean Diabetes.2024; 25(1): 16.     CrossRef
  • Genitourinary Tract Infections in Patients Taking SGLT2 Inhibitors
    Veraprapas Kittipibul, Zachary L. Cox, Supavit Chesdachai, Mona Fiuzat, JoAnn Lindenfeld, Robert J. Mentz
    Journal of the American College of Cardiology.2024; 83(16): 1568.     CrossRef
  • Effects of Sodium–Glucose Co-Transporter 2 Inhibitors on Serum Chloride Concentrations in Patients with Heart Failure
    Ivana Jurin, Vanja Ivanović Mihajlović, Zrinka Šakić, Marin Pavlov, Tomislav Šipić, Petra Vitlov, Hrvoje Falak, Danijela Grizelj, Šime Manola, Mario Udovičić
    Journal of Cardiovascular Development and Disease.2024; 11(11): 364.     CrossRef
  • Hemodynamic Effects of SGLT2 Inhibitors in Patients with and Without Diabetes Mellitus—A Narrative Review
    Roxana Brata, Andrei Vasile Pascalau, Ovidiu Fratila, Ioana Paul, Mihaela Mirela Muresan, Andreea Camarasan, Tiberia Ilias
    Healthcare.2024; 12(23): 2464.     CrossRef
  • Synopsis of the Korean Society of Nephrology 2023 Practical Recommendations for the Management of Diabetic Kidney Disease
    Sungjin Chung
    The Korean Journal of Medicine.2023; 98(6): 270.     CrossRef
Close layer
Original Article
Clinical Study
Characteristics of Body Composition and Muscle Strength of North Korean Refugees during South Korean Stay
Sun Wook Cho, So Hee Lee, Eun Sil Koh, Si Eun Kim, Seok Joong Kim
Endocrinol Metab. 2015;30(4):551-556.   Published online December 31, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.4.551
  • 6,487 View
  • 44 Download
  • 3 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   
Background

The aim of this study was to investigate the changes of body composition and muscle strength of North Korean refugees (NKRs) according to their duration of stay in South Korea.

Methods

NKRs who volunteered and were living in South Korea, aged 20 to 75 years were recruited. Body compositions were analyzed by bioelectrical impedance analysis. Muscle strength was measured with the hand grip test. Demographic and migration information was obtained with a questionnaire.

Results

A total of 158 volunteers were recruited at a mean age of 48.3±11.4 years. The mean time from when they escaped from North Korea and arrived in South Korea was 5.8±4.3 years. Height, weight, and body surface area were significantly smaller in all NKRs compared to South Korean controls, except for women aged over 50 years. In females of younger ages (<50 years), NKRs with more than a 4-year stay in South Korea had a higher weight and fat mass than that of those who had a shorter stay (less than 4 years) in South Korea. All NKRs had a weaker grip strength than that of the age-matched controls from South Korea.

Conclusion

The NKRs showed relatively smaller physiques and weaker muscle strength than that of the South Korean controls. In younger female NKRs, shorter South Korean stay group showed small body weight and fat mass than that of longer South Korean stay group. Specific health support programs might be needed.

Citations

Citations to this article as recorded by  
  • Physical Fitness and Health-Related Quality of Life Among North Korean Defectors: Focusing on the Jangmadang and Arduous March Generations
    Do-Hee Kim, Jung-Woo Oh, Yeon-Soo Kim, Yunmin Han, Younghwan Choi, Joo-Young Lee
    Journal of The Korean Society of Living Environmental System.2025; 32(6): 753.     CrossRef
  • Thermal Perception and Wearing Habits among North Korean Residents: An Integrated Approach to Living Environments Based on the Experiences of North Korean Defectors
    Do-Hee Kim, Young-hee Kim, Yeo-Sang Yoon, Jung-Woo Oh, Joo-Young Lee
    Journal of The Korean Society of Living Environmental System.2025; 32(6): 790.     CrossRef
  • Assessment of diet quality of adults from North Korea: using nutrition quotient (NQ) for Korean adults
    SaeByeol Kwon, Kyoung-Nam Kim, Moon-Kyung Shin
    Journal of Nutrition and Health.2023; 56(2): 217.     CrossRef
  • Associations between grip strength, cardiorespiratory fitness, cardiovascular risk and mental health in forcibly displaced people from a Greek refugee camp
    Markus Gerber, Konstantinia Filippou, Florian Knappe, Ioannis D. Morres, Emmanouil Tzormpatzakis, Elsa Havas, Harald Seelig, Flora Colledge, Sebastian Ludyga, Marianne Meier, Yannis Theodorakis, Roland von Känel, Uwe Pühse, Antonis Hatzigeorgiadis
    Scientific Reports.2023;[Epub]     CrossRef
  • Weight Gain Predicts Metabolic Syndrome among North Korean Refugees in South Korea
    Yoon Jung Kim, Yo Han Lee, Yun Jeong Lee, Kyeong Jin Kim, Sin Gon Kim
    International Journal of Environmental Research and Public Health.2021; 18(16): 8479.     CrossRef
  • Prevalence of General and Central Obesity and Associated Factors among North Korean Refugees in South Korea by Duration after Defection from North Korea: A Cross-Sectional Study
    Yoon Jung Kim, Sin Gon Kim, Yo Han Lee
    International Journal of Environmental Research and Public Health.2018; 15(4): 811.     CrossRef
Close layer

Endocrinol Metab : Endocrinology and Metabolism
TOP